Clinical Trials Logo

Visceral Fat clinical trials

View clinical trials related to Visceral Fat.

Filter by:
  • None
  • Page 1

NCT ID: NCT06353880 Not yet recruiting - Obesity Clinical Trials

Obesity With Sperm Quality in Men With Fertility Need

Start date: May 2024
Phase:
Study type: Observational [Patient Registry]

This study aims to investigate the impact of different types of obesity on sperm quality. Participants will be divided into three groups: a normal BMI group, an obese group without pudendal fat wrapping the testicles, and an obese group with pudendal fat wrapping the testicles. Sperm quality parameters will be compared among these groups to assess potential differences associated with different types of obesity.

NCT ID: NCT06112197 Enrolling by invitation - Insulin Resistance Clinical Trials

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

Start date: January 5, 2024
Phase:
Study type: Observational

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

NCT ID: NCT03639350 Completed - Visceral Fat Clinical Trials

The Healthy Diet and Lifestyle Study

HDL
Start date: September 12, 2016
Phase: N/A
Study type: Interventional

This pilot study aims to develop a study design to test the difference between a fasting diet and a heart healthy diet, assess participants' adherence to the study design, and to test whether either diet helps to reduce fat wrapped around the organs in the stomach area and total body fat in East Asian American adults. 70 men and women residents of Oahu Hawai'i, aged 35-55, who are overweight or obese and have moderate to high amounts of fat around organs in the stomach area, of Japanese, Chinese, or Korean ancestry, will be equally distributed to either the fasting diet or the heart healthy diet and asked to follow this diet for the 12-week study. Each diet has set requirements for energy, protein, carbohydrates, and fat. The fasting diet has two days of fasting, where participants will be asked to follow a low carbohydrate- low energy diet, and five days of a balanced diet without any energy restriction (the Mediterranean diet). The other group will follow a heart healthy diet (Dietary Approaches to Stop Hypertension diet) for all seven days without any energy restriction. Both groups will be asked to follow a moderate exercise program (one hour of walking five days a week). Dietitians will provide information on diet and exercise requirements to the participants at the start of the study. Dietitians will contact the participants seven times, primarily by phone, to offer support and to check if the participants are following prescribed diet and exercise plans. Participants will use a mobile phone app to take images of all foods and drinks for four days at the beginning, middle and end of the 12-week study. Body measurements, including measurements of body fat, will be taken at the beginning and end of the study by trained clinic staff. The analysis of the food images, participants' self-reported compliance to diet and exercise plans, and body measurements will be used to determine if the study design and participant compliance to the study are successful, and to assess which diet is better at reducing total body fat and fat around the organs in the stomach region.

NCT ID: NCT03135132 Completed - Weight Loss Clinical Trials

The Effect of Mild Weight Loss on Circulating Metabolite Profiles

Start date: June 2015
Phase: N/A
Study type: Interventional

To determine whether low calorie diet (LCD)-induced weight reduction caused changes in plasma metabolites and metabolic traits from baseline.

NCT ID: NCT02992639 Completed - Liver Dysfunction Clinical Trials

Weight Loss Effect on Circulating Liver Enzymes

Start date: June 2015
Phase: N/A
Study type: Interventional

To investigate weight loss effect with mild calorie restriction on circulating levels of liver enzymes in nondiabetic and overweight subjects with high visceral fat area [visceral fat area (VFA) at L4 ≥ 100 cm²].

NCT ID: NCT01344694 Not yet recruiting - Atherosclerosis Clinical Trials

Epicardial Fat, Visceral Fat and Coronary Atherosclerosis

Start date: July 2011
Phase: N/A
Study type: Observational

Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease. The independent role of epicardial fat deposition in cardiovascular risk remains unclear.

NCT ID: NCT01282892 Active, not recruiting - Atherosclerosis Clinical Trials

Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis

Start date: February 2009
Phase: N/A
Study type: Observational

Visceral fat or peri-omental fat is increasingly associated with metabolic syndrome, a condition carrying a high risk of coronary artery disease. The independent role of Visceral Fat in cardiovascular risk remains unclear. Patients with excess of visceral fat and NAFLD patients will have higher prevalence of coronary atherosclerosis plaques independently by metabolic syndrome diagnosis. Suggesting that the presence of visceral fat and/or fatty liver will be considered an important condition to optimize the cardiovascular risk stratification